Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response

Hamadi, A; Grigg, AP; Dobie, G; Burbury, KL; Schwarer, AP; Kwa, FA; Jackson, DE

Jackson, DE (reprint author), RMIT Univ, Sch Hlth & Biomed Sci, Thrombosis & Vasc Dis Lab, POB 71, Bundoora, Vic 3083, Australia.

THROMBOSIS AND HAEMOSTASIS, 2019; 119 (7): 1112

Abstract

Both nilotinib, a second-generation tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukaemia (CML), and ponatinib, a third-g......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索